1. Holmes Peter , The Energetics of Western Herbs, Snow Lotus Press, 1997.
רפואת צמחים אינטגרטיבית, ראן צמחים בע"מ, 2003
2. Mills. S, Bone K, Principles and Practice of Phytotherapy. Churchill Livingstone, 2000.
3. Saljic J. Ointment for the treatment of burns. Ger Offen. 1975; 2: 406-452.
4.
Rao SG, Laxminarayana AU, Saraswathi LU, Padma GM, Ganesh R, Kulkarni
DR. Calendula and Hypericum: two homeopathic drugs promoting wound
healing in rats. Fitoterapia. 1991; 6: 508-510.
5. Kasper S. Hypericum perforatum--a review of clinical studies. Pharmacopsychiatry 34:S51-S55
6.
Whiskey E, Werneke U, Taylor D, A systematic review and meta-analysis
of Hypericum perforatum in depression: a comprehensive clinical review, ,
Int Clin Psychopharmacol, 2001 Sep;16(5):239-52
7. Roder C, Schaefer
M, Leucht S, Meta-analysis of effectiveness and tolerability of
treatment of mild to moderate depression with St. John's Wort, Fortschr
Neurol Psychiatr., 2004 Jun;72(6):330-43.
8. Hansgen KD, Vesper J,
Ploch M. Multicenter double-blind study examining the antidepressant
effectiveness of the Hypericum extract LI 160. J Geriatr Psychiatry
Neurol 1994;7:S15-S18.
9. Kasper S, Anghelescu IG, SZegedi A, Dienel
A, Kieser M, Superior efficacy of St John's wort extract WS 5570
compared to placebo in patients with major depression a randomized,
double-blind, placebo-controlled, multi-center trial, BMC Med. 2006 Jun
23;4:14
10. Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness
of St. John's wort in major depression: a randomized controlled trial.
JAMA 2001;285:1978-1986.
11. Meruelo, D., G. Lavie & D. Lavie.
1988. "Therapeutic agents with dramatic antiretroviral activity and
little toxicity at effective doses: aromatic polycyclic diones hypericin
and pseudohypericin," Proc. Natl. Acad. Sci. 85: 5230-5234.
12. Wood
S, Huffman J, Weber N, Andersen D, North J, Murray B, et al. Antiviral
activity of naturally occurring anthraquinones and anthraquinone
derivatives. Planta Med. 1990; 56: 651-652.
13. Lopez-Bazzocchi I,
Hudson JB, Towers GH. Antiviral activity of the photoactive plant
pigment hypericin. Photochem Photobiol. 1991; 54: 95-98.
14. J. T.
Neary, S. R. Whittemore, Y. Bu, H. Mehta, Y.-F. Shi , Biochemical
Mechanisms of Action of Hypericum LI 160 In Glial and Neuronal Cells:
Inhibition Of Neurotransmitter Uptake and Stimulation of Extracellular
Signal Regulated Protein Kinase, Pharmacopsychiatry 2001; 34: 103-107
15. Laakman G, Schule C, Baghai T, Kieser M. St. John’s wort in mild to moderate depression: the relevance of
hyperforin for the clinical efficacy. Pharmacopsychiatry 1998;31:S54-S59.
16.
Chatterjee SS, Bhattacharya SK, Wonnemann M, et al. Hyperforin as a
possible antidepressant component of Hypericum extracts. Life Sciences
1998;63:499-510.
17. Woelk H, Comparison of St John's wort and
imipramine for treating depression randomised controlled trial, BMJ 2000
Sep 2;321(7260):536-9.
18. Schrader E, Equivalence of St John's wort
extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression, Int Clin Psychopharmacol 2000 Mar;15(2):61-8.
19. Roby CA, Anderson GD, Kantor E & al, St. John's wort effect on CYP3A4 activity. Clin Pharmacol Ther, 2000; 67: 451-57.